Last update 18 Oct 2025

NH160030

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
NH160030
Target
μ opioid receptor
Action
agonists
Mechanism
μ opioid receptor agonists(Mu opioid receptor agonists)
Therapeutic Areas
Nervous System DiseasesOther Diseases
Active Indication
Cancer PainAnesthesia
Inactive Indication-
Originator Organization
Jiangsu Nhwa Pharmaceutical Co., Ltd.Jiangsu Nhwa Pharmaceutical Co., Ltd.
Active Organization
Jiangsu Nhwa Pharmaceutical Co., Ltd.Jiangsu Nhwa Pharmaceutical Co., Ltd.Shanghai Shujing Biotechnology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with NH160030
CTR20244547
/ RecruitingPhase 1
一项在非癌性慢性疼痛患者中评价NH160030片单次给药的安全性、耐受性、药代动力学和食物影响的随机、双盲、安慰剂对照、剂量爬坡的I期临床研究
[Translation] A randomized, double-blind, placebo-controlled, dose-escalating Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and food effects of a single dose of NH160030 tablets in patients with non-cancer chronic pain
CTR20253966
/ Not yet recruitingPhase 1
一项在癌痛患者中评价NH160030片多次给药剂量递增的安全性、耐受性、药代动力学、药效动力学的随机、双盲双模拟、阳性药对照的Ib期临床研究
[Translation] A randomized, double-blind, double-dummy, active-controlled Phase Ib clinical study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of NH160030 tablets after multiple dose escalation in patients with cancer pain
100 Clinical Results associated with NH160030
Login to view more data
100 Translational Medicine associated with NH160030
Login to view more data
100 Patents (Medical) associated with NH160030
Login to view more data
100 Deals associated with NH160030
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cancer PainPhase 1
China
Jiangsu Nhwa Pharmaceutical Co., Ltd.Jiangsu Nhwa Pharmaceutical Co., Ltd.
19 Dec 2024
AnesthesiaIND Application
China
Shanghai Shujing Biotechnology Co., Ltd.
30 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free